Literature DB >> 31864787

The impact of rurality on opioid-related harms: A systematic review of qualitative research.

Natalie Thomas1, Katinka van de Ven2, Kyle J D Mulrooney3.   

Abstract

INTRODUCTION: Over the past decade, there has been mounting recognition that opioid use and related mortality and morbidity is a significant public health problem in rural, non-urban areas across the globe. Taking what has been termed the 'opioid crisis' as a starting off point, this article aims to systematically review the qualitative literature on the ways in which rurality shapes the risk for opioid-related harm.
METHODS: A systematic review was undertaken using database searches and secondary reference list searches for qualitative literature on rural and non-urban opioid-related harms. A total of 32 qualitative studies met the inclusion criteria. Data extraction was performed in NVivo 12 using a codebook based on the 'risk environment' framework.
RESULTS: The findings explore how rurality shapes the risk environment for opioid-related harms through four environment influences: (1) economic conditions, including economic transition and deindustrialisation that has occurred in many rural areas, and the high levels of economic distress experienced by rural residents; (2) physical conditions, including a lack of infrastructure and recreation opportunities, larger geographic distances, and limited transportation; (3) social conditions, where social networks could be both protective but also amplify risk through a lack of knowledge about treatment and risk behaviours, a lack of anonymity and stigmatisation of people who use opioids in rural areas; and (4) policy conditions including limited coverage and availability of harm reduction and drug treatment services, and stigmatising service provider practices.
CONCLUSIONS: The impact of rurality on risk of opioid-related harm is multifaceted. We suggest that future research on rural opioid use would benefit from drawing on the theoretical toolkit of rural criminology to attend to the ways the 'rural crisis', and attendant insecurities, anxieties and strains, impacts upon rural communities and shapes risk, along with how socio-cultural characteristics of the rural 'organise' risks of drug use.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alcohol and other drugs; Non-urban; Opioids; Qualitative research; Risk environments; Rural; Systematic review

Year:  2019        PMID: 31864787     DOI: 10.1016/j.drugpo.2019.11.015

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  10 in total

1.  Validation and threshold identification of a prescription drug monitoring program clinical opioid risk metric with the WHO alcohol, smoking, and substance involvement screening test.

Authors:  Gerald Cochran; Jennifer Brown; Ziji Yu; Stacey Frede; M Aryana Bryan; Andrew Ferguson; Nadia Bayyari; Brooke Taylor; Margie E Snyder; Elizabeth Charron; Omolola A Adeoye-Olatunde; Udi E Ghitza; T Winhusen
Journal:  Drug Alcohol Depend       Date:  2021-09-24       Impact factor: 4.492

2.  Contraception and Healthcare Utilization by Reproductive-Age Women Who Use Drugs in Rural Communities: a Cross-Sectional Survey.

Authors:  Ximena A Levander; Canyon A Foot; Sara L Magnusson; Ryan R Cook; Jerel M Ezell; Judith Feinberg; Vivian F Go; Kathryn E Lancaster; Elizabeth Salisbury-Afshar; Gordon S Smith; Ryan P Westergaard; April M Young; Judith I Tsui; P Todd Korthuis
Journal:  J Gen Intern Med       Date:  2022-06-15       Impact factor: 6.473

3.  Conceptualizing the Socio-Built Environment: An Expanded Theoretical Framework to Promote a Better Understanding of Risk for Nonmedical Opioid Overdose Outcomes in Urban and Non-Urban Settings.

Authors:  Barbara Tempalski; Leslie D Williams; Marynia Kolak; Danielle C Ompad; Julia Koschinsky; Sara L McLafferty
Journal:  J Urban Health       Date:  2022-06-07       Impact factor: 5.801

4.  In Their Own Words: How Opioids Have Impacted the Lives of "Everyday" People Living in Appalachia.

Authors:  Patricia N E Roberson; Gina Cortez; Laura Hunt Trull; Kathrine Lenger
Journal:  J Appalach Health       Date:  2020-09-01

5.  Kratom Use in the US: Both a Regional Phenomenon and a White Middle-Class Phenomenon? Evidence From NSDUH 2019 and an Online Convenience Sample.

Authors:  Jeffrey M Rogers; Kirsten E Smith; Justin C Strickland; David H Epstein
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

6.  Intersectional structural vulnerability to abusive policing among people who inject drugs: A mixed methods assessment in California's central valley.

Authors:  Joseph Friedman; Jennifer L Syvertsen; Philippe Bourgois; Alex Bui; Leo Beletsky; Robin Pollini
Journal:  Int J Drug Policy       Date:  2020-10-28

Review 7.  The Opioid/Overdose Crisis as a Dialectics of Pain, Despair, and One-Sided Struggle.

Authors:  Samuel R Friedman; Noa Krawczyk; David C Perlman; Pedro Mateu-Gelabert; Danielle C Ompad; Leah Hamilton; Georgios Nikolopoulos; Honoria Guarino; Magdalena Cerdá
Journal:  Front Public Health       Date:  2020-11-05

8.  The mediation and moderation effect of social support on the relationship between opioid misuse and suicide attempts among native American youth in New Mexico: 2009-2019 Youth Risk Resiliency Survey (NM-YRRS).

Authors:  Daniel Opoku Agyemang; Erin Fanning Madden; Kevin English; Kamilla L Venner; Rod Handy; Tejinder Pal Singh; Fares Qeadan
Journal:  BMC Psychiatry       Date:  2022-04-05       Impact factor: 3.630

9.  Predictors of having naloxone in urban and rural Oregon findings from NHBS and the OR-HOPE study.

Authors:  Lauren Lipira; Gillian Leichtling; Ryan R Cook; Judith M Leahy; E Roberto Orellana; P Todd Korthuis; Timothy W Menza
Journal:  Drug Alcohol Depend       Date:  2021-07-21       Impact factor: 4.852

10.  HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service.

Authors:  Magally Torres-Leguizamon; Emmanuel G Reynaud; Thomas Néfau; Catherine Duplessy
Journal:  Harm Reduct J       Date:  2020-08-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.